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Severe subcutaneous edema is rare in dermatomyositis (DM). Such patients usually have a highly active
disease, which requires aggressive treatment. To date, there are 14 reported cases of generalized edema
secondary to adult DM. We described a severe case of DMmanifesting generalized edema, oropharyngeal
dysphagia, and dysarthria. A 44-year-old female presented with a typical rash of DM, proximal muscle
weakness, andmarked swelling of the limbs and face. The ﬁndings in the skin biopsy,muscle enzymes, and
electromyography were consistent with DM. No internal malignancy was detected. After a brief initial
response to oral dexamethasone, the patient experienced a sudden worsening of muscle weakness with
dysarthria and an inability to swallow even saliva. Amagnetic resonance imaging study revealed edema of
the subcutaneous tissue and muscles. The symptoms improved gradually in 2 months after intravenous
pulse corticosteroid therapy. Generalized subcutaneous edema is a very rare manifestation of DM that can
occur as a presenting symptom. It appears to be a hallmark of a severe DM that requires prompt and
aggressive treatment. Additional cases are needed to establish guidelines for treatment of this rare variant.
Copyright  2013, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction oropharyngeal dysphagia and dysarthria, which improved gradu-Dermatomyositis (DM) is an autoimmune disorder that causes
proximal muscle weakness and manifests with several character-
istic skins rashes, including heliotrope periorbital rash, Gottron’s
papules, Shawl sign, V sign, and periungual telangiectasia. Diag-
nosis of DM relies on typical clinical manifestations, elevation of
serum muscle enzyme levels, and a characteristic electromyo-
graphic (EMG) pattern. Periorbital edema is commonly seen in in-
ﬂammatory myopathy, but generalized edema is an unusual
presenting feature. To date, there are 14 reported cases of gener-
alized edema secondary to adult DM.1e10 Cases of juvenile DMwith
anasarca were also reported.11e14 Such patients usually have a
highly active disease with pronounced muscle weakness and
dysphagia, which require aggressive treatment. We report a female
patient who had acute edematous DM, with a relatively good initial
response to oral dexamethasone. After a brief improvement, she
experienced a sudden worsening of muscle weakness, withy have no ﬁnancial or non-
tter or materials discussed in
logy, National Cheng Kung
-Li Rd, Tainan City, Taiwan.
e).
iwanese Dermatological Associatioally in 2 months after intravenous pulse corticosteroid therapy.
Case Report
A 44-year-old female without past history of renal or heart disease,
presented with a 2 month history of erythematous maculopapular
skin rash over the face, V-neck, back, and all extremities. She also
experienced proximal muscle weakness in association with
generalized swelling for 2 weeks prior to admission. The patient
noted a body weight gain of 7 kg in 4 weeks (from 68 kg to 75 kg).
Physical examination revealed Gottron’s papules on the dorsal
hands (Figure 1), a periorbital heliotrope rash, and a generalized
non-pitting edema, which was most pronounced over the face and
upper limbs, especially the hands. A neurological examination
showed decreasedmuscle power in her shoulder and pelvic girdles.
Laboratory evaluations revealed a white blood cell count of 6700/
mm,3 a hemoglobin level of 10.8 g/dL, a platelet count of 319,000/
mm3, an elevated muscle enzyme creatine kinase of 992 IU/L,
aspartate transaminase (AST) of 106 U/L, and alanine transaminase
(ALT) of 50 U/L. Albumin was 2.8 g/dL, but there was no proteinuria
on urinalysis. Renal and thyroid function test results were unre-
markable. Circulating antinuclear antibodies were weakly positive
(1:80), but anti-Jo-1 antibody, anti-Ro/La antibody, anti-
ribonucleoprotein antibody, anti-Smith antibody, andn. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 Generalized edema in a 44-year-old woman with acute dermatomyositis.
Note diffuse swelling of the hands and ﬁngers with Gottron’s papules and prominent
periungual erythema.
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electrocardiography, and sonography of the abdomen were unre-
markable. Sonography of the bilateral upper extremities showed
diffuse edema of subcutaneous and fascia layers (Figure 2). Histo-
logical examination of a skin lesion over the right postauricular area
showed vacuolar interface dermatitis compatible with DM. The
patient refused to undergo EMG.With the exclusion of other causes
for limb edema, a diagnosis of DMwith severe subcutaneous edema
was made. She was then treated with oral dexamethasone 6 mg/
day, which resulted in an improvement in muscle weakness and
edema in 9 days, and markedly decreased muscle enzymes. A
search for internal malignancy produced negative results. The pa-
tient was discharged on oral dexamethasone 6 mg/day.
After 2 weeks, she experienced a sudden worsening of muscle
weakness, with elevation of muscle enzyme levels, in association
with dysarthria and an inability to swallow even her saliva. Mag-
netic resonance imaging from the nasopharynx to the bilateralFigure 2 Imaging of this patient. Diffuse edema of subcutaneousupper limbs showed edematous changes of hyperintensity at the
muscles, subcutaneous regions, and intermuscular fasciae
(Figure 3). EMG revealed ﬁndings consistent with inﬂammatory
myopathy. Intravenous methylprednisolone 80 mg/day (40 mg bid)
was initiated, but the clinical response was slow. Her dysphagia
remained severe, and she was placed on a nasogastric tube for
feeding. Myasthenia gravis was excluded by normal responses in a
repetitive nerve stimulation test and a negative neostigmine
diagnostic test.
Due to elevated hepatic enzymes (AST/ALT ¼ 138/85 U/L),
methotrexate was not used as an alternative. After administering
intravenous methylprednisolone 80 mg/day for 7 days, pulse
intravenous methylprednisolone (500 mg/day) was administered
for 5 days. This was followed by intravenous methylprednisolone
80 mg/day for another 11 days and then oral prednisolone 90 mg/
day for 4 days prior to discharge. Despite amarked decline in serum
muscle enzyme levels and improvement of subcutaneous edema,
there was no appreciable clinical response in dysphagia and prox-
imal muscle strength. The patient was then transferred to the
neurology ward for further evaluation and treatment. Non-
enhanced brain computed tomography was performed and found
no deﬁnite intracranial abnormality, which supported the theory
that the dysarthria and poor soft palate elevation was a manifes-
tation of DM activity. The patient later developed right lung
pneumonia with fever and productive coughs. After the infection
was treated with parenteral antibiotics, she was discharged on oral
prednisolone 90 mg/day, with a slight improvement of proximal
muscle weakness and dysphagia (the nasogastric tube was still in
place). One month after discharge, the nasogastric tube was suc-
cessfully removed, with the resumption of a normal diet. Currently,
she is on prednisolone (40 mg/day), and her DM is improving both
biochemically and clinically.Discussion
We described a severe case of DM manifesting marked proximal
muscle weakness in association with a generalized non-pitting
edema (most pronounced over the face and upper limbs), and
oropharyngeal dysphagia. Themost common causes of anasarca are
hypoalbuminemia, heart failure, cirrhosis, and renal insufﬁciency.5
Other causes may be related to deep vein thrombosis, hypothy-
roidism, medications, and malignancy.6 Despite an extensiveand fascia layers of bilateral upper arms by ultrasonography.
Figure 3 Edema with hyperintensity of the muscles and subcutaneous regions of
bilateral upper extremities by magnetic resonance imaging (coronal view, fat-
suppressed T2-weighted).
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except the active DM. Severe widespread subcutaneous edema or
anasarca in association with both juvenile and adult-onset DM has
been reported, but only very rarely.
Pathogenesis of generalized edema in DM is unclear, but capil-
lary inﬂammation with increased vascular permeability has been
suggested.5 Generalized subcutaneous edema, which denotes a
very active inﬂammation, is perhaps caused by increased capillary
permeability and endothelial damage, due to deposition of immune
complexes as documented by the presence of vasculitis of small
blood vessels and edema of the dermis in skin biopsy.8 All patients
had improved swelling only after aggressive immunotherapy, a
ﬁnding which strongly suggested that the edema had a close
relation to the pathophysiology of DM.9
The clinical features of the 14 reported cases of DM associated
with generalized edema1e10 and the present case are summa-
rized in Table 1. Altogether, there are 10 females and 5 males,
with ages ranging from 23 years to 78 years (mean ¼ 49.7 years),
a ﬁnding consistent with the female predominance in adult pa-
tients with DM. Edema affects the limbs, trunk, and face in
various combinations and usually begins early in the course of
the disease (< 10 weeks) in most patients. A highly activeTable 1 Characteristics of 15 patients with edema associated with adult dermatomyosit
AuthorsRef Sex Age (y) Disease
duration (wk)
Predominant site of ede
Nitsche1 F 62 20 Upper limbs, trunk
Smyth et al2 F 27 4 Forearms
Gorelik et al3 M 31 2 Upper-lower limbs
Gorelik et al3 M 63 2 Left arm
Mroue et al4 F 78 1 Upper limbs
Werner de Castro et al5 M 40 56 Upper-lower limbs, tru
Ito et al6 F 78 1.4 Upper-lower limbs
Lee et al7 F 48 4 Face, upper-lower limb
Haroon et al8 F 61 1 Face, upper-lower limb
Chai et al9 M 62 8 Upper-lower limbs
Chai et al9 F 23 16 Upper-lower limbs
Chai et al9 F 38 12 Lower limbs
Chai et al9 M 38 N/A Upper limbs
Jung et al10 F 52 40 Upper-lower limbs, tru
Our patient F 44 8 Face, upper limbs
AZA ¼ azathioprine; CPT ¼ corticosteroid pulse therapy; CS ¼ corticosteroids; CYC
MMF ¼ mycophenolate mofetil; MTX ¼ methotrexate; N/A ¼ not available.disease, with pronounced muscle weakness and dysphagia, or
esophageal involvement, is another characteristic of this variant.5
Signiﬁcant dysphagia, noted in the 10 previously reported cases,
often appears concomitantly with the resolution of edema and a
decline in serum muscle enzyme levels.6 However, our patient
suffered from dysphagia prior to the resolution of edema, and the
dysphagia continued despite the normalization of muscle
enzyme levels and gradual improvement of proximal muscle
strength.
Although most of the patients initially presented with a very
active disease, its prognosis seems to be relatively good (Table 1).
Only one patient died5; the other patients eventually had resolu-
tion of anasarca after immunosuppressant therapy. One case
recovered, without any treatment.3
Treatment of DM associated with generalized edema varied.
Most patients’ symptoms responded to a systemic corticosteroid,
followed by methotrexate, intravenous immunoglobulin (IVIG),
azathioprine, cyclosporine, and mycophenolate mofetil (Table 1).
Glucocorticoids can decrease the severity of edema through
potent anti-inﬂammatory and immunosuppressive effects.7 Chai
et al9 reported the lack of signiﬁcant improvement with cortico-
steroids alone, and more aggressive immunotherapy, including
methotrexate and IVIG, was required. IVIG has been shown to be
effective in a case resistant to corticosteroids, azathioprine, and
mycophenolate mofetil, and also in patients with bulbar involve-
ment.8 IVIG therapy, however, was not effective in some cases;
one such case responded to intravenous pulse methylpredniso-
lone, followed by high dose oral prednisolone.7 Rituximab has
been used to treat refractory inﬂammatory myopathies.15 Its
therapeutic effect in DM associated with generalized edema is
unknown, but it may be considered as an alternative for the re-
fractory cases.7
In treatment-refractory cases, it is also noteworthy to consider a
positron emission tomography (PET) scan to exclude underlying
malignant diseases, as illustrated in the case reported by Haroon
et al.8 The patient’s muscle weakness and edema were resistant to
corticosteroids, azathioprine, and mycophenolate mofetil. Her
initial malignancy screen was negative, but a PET scan revealed a
cervical tumor along with a suspected metastatic lung nodule. The
refractory DM was brought under control after the tumors were
treated.8
In the present case, the muscle weakness and generalized
edema showed a good, but transient improvement to oral dexa-
methasone initially, which was soon followed by a marked wors-
ening of the muscle weakness with edema and disabling dysphagiais.
ma Dysphagia Treatment Associated internal
malignancy
Outcome
þ CS N/A Recovered
e CS, AZA e Recovered
þ CS, IVIG e Recovered
e None e Recovered
e CS e Recovered
nk þ CS, IVIG e Died
þ CS e Recovered
s þ CS, MTX, IVIG, CPT e Recovered
s, trunk þ CS, AZA MMF, IVIG Cervical cancer Recovered
þ CS, MTX, IVIG N/A Recovered
e CS, MTX, IVIG N/A Recovered
þ CS, MTX, IVIG N/A Recovered
þ CS, MTX, IVIG N/A Recovered
nk þ CS, IVIG, AZA, CYC e Recovered
þ CS, CPT e Recovered
¼ cyclosporine; F ¼ female; IVIG ¼ intravenous immunoglobulin; M ¼ male;
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Myasthenia gravis was considered as a potential cause for the pa-
tient’s severe bulbar involvement and poor response to cortico-
steroids. However, it was excluded by normal responses in a
repetitive nerve stimulation test and a negative neostigmine
diagnostic test. Alternative treatments, such as methotrexate,
azathioprine, or IVIG, were not prescribed to our patient, due to
elevated hepatic enzymes, a slower-onset of action, or not being
covered by health insurance, respectively.
In conclusion, generalized subcutaneous edema is a very rare
manifestation of DM that can occur as a presenting symptom. It
may be a hallmark of a severe form of DM that requires prompt and
aggressive treatment. The clinical course of generalized edema
varies, and early recognition is essential for better disease control.
Additional cases are needed to establish guidelines for treatment of
this rare variant.
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